Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04858594 · ClinicalTrials.gov registry record
Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy
A clinical trial, sponsored by Masonic Cancer Center, University of Minnesota.
- Terminated
- Registry status
- 3
- Enrollment target
NCT04858594: Clinical Trial study, sponsored by Masonic Cancer Center, University of Minnesota.
NCT04858594 is a clinical trial that was terminated before completion, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04858594 was terminated before completion, sponsored by Masonic Cancer Center, University of Minnesota.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This is a prospective, observational study to establish the connection between periodontitis and BSI in AML patients planning to receive intensive chemotherapy.
Primary Outcome
Number of participants experiencing Blood stream infections (BSI) by day 28 of chemotherapy
Interventions
- OTHER Planned Chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-05-04 |
| Est. Completion | 2022-02-28 |
Why NCT04858594 stopped before completion
NCT04858594 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Planned Chemotherapy is the first listed.
NCT04858594 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04858594 about?
NCT04858594 is a clinical study titled "Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy". This is a prospective, observational study to establish the connection between periodontitis and BSI in AML patients planning to receive intensive chemotherapy.
What is the current status of trial NCT04858594?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2021-05-04. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT04858594?
The interventions under investigation include: Planned Chemotherapy (OTHER).
Who is sponsoring clinical trial NCT04858594?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI